Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation

European Journal of Human Genetics

Volumn 19, Issue 8, 2011, Pages 870-874

  Jongmans, Marjolijn C J ^a   Van Der Burgt, Ineke ^a   Hoogerbrugge, Peter M ^a   Noordam, Kees ^a   Yntema, Helger G ^a   Nillesen, Willy M ^a   Kuiper, Roland P ^a   Ligtenberg, Marjolijn J L ^a   Van Kessel, Ad Geurts ^a   Van Krieken, J Han J M ^a   Kiemeney, Lambertus A L M ^a   Hoogerbrugge, Nicoline ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE SHP 2;

ADOLESCENT; ADULT; AGED; ANGIOSARCOMA; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIOID SARCOMA; FEMALE; GENE MUTATION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MASTOCYTOSIS; MEDICAL HISTORY; MORBIDITY; NETHERLANDS; NOONAN SYNDROME; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MUTATION; NEOPLASMS; NETHERLANDS; NOONAN SYNDROME; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; YOUNG ADULT;

EID: 79960636001     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.37     Document Type: Article

References (46)

1. Tartaglia M, Zampino G, Gelb BD: Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol 2010; 1: 2-26.
2. Choong K, Freedman MH, Chitayat D, Kelly EN, Taylor G, Zipursky A: Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol 1999; 21: 523-527. (Pubitemid 30305988)
3. Lauchle JO, Braun BS, Loh ML, Shannon K: Inherited predispositions and hyperactive Ras in myeloid leukemogenesis. Pediatr Blood Cancer 2006; 46: 579-585.
4. Tartaglia M, Niemeyer CM, Shannon KM, Loh ML: SHP-2 and myeloid malignancies. Curr Opin Hematol 2004; 11: 44-50. (Pubitemid 38021720)
5. Chantrain CF, Jijon P, De RT et al: Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation. Pediatr Blood Cancer 2007; 48: 101-104. (Pubitemid 44871599)
6. Ferrero GB, Baldassarre G, Delmonaco AG et al: Clinical and molecular characterization of 40 patients with Noonan syndrome. Eur J Med Genet 2008; 51: 566-572.
7. Karow A, Steinemann D, Gohring G et al: Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome. Leukemia 2007; 21: 1303-1305. (Pubitemid 46831821)
8. La Starza R, Rosati R, Roti G et al: A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukaemia in Noonan Syndrome. Leukemia 2007; 21: 830-833. (Pubitemid 46444578)
9. Lo FS, Kuo TT, Wang CJ, Kuo MT, Kuo MC: Hodgkin's lymphoma in a patient with Noonan syndrome with germ-line PTPN11 mutations. Int J Hematol 2008; 88: 287-290.
10. Matsubara K, Yabe H, Ogata T, Yoshida R, Fukaya T: Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation. Am J Hematol 2005; 79: 171-172. (Pubitemid 40770681)
11. Roti G, La SR, Ballanti S et al: Acute lymphoblastic leukaemia in Noonan syndrome. Br J Haematol 2006; 133: 448-450.
12. Cotton JL, Williams RG: Noonan syndrome and neuroblastoma. Arch Pediatr Adolesc Med 1995; 149: 1280-1281.
13. Ijiri R, Tanaka Y, Keisuke K, Masuno M, Imaizumi K: A case of Noonan's syndrome with possible associated neuroblastoma. Pediatr Radiol 2000; 30: 432-433. (Pubitemid 30330454)
14. Jung A, Bechthold S, Pfluger T, Renner C, Ehrt O: Orbital rhabdomyosarcoma in Noonan syndrome. J Pediatr Hematol Oncol 2003; 25: 330-332. (Pubitemid 36506224)
15. Khan S, McDowell H, Upadhyaya M, Fryer A: Vaginal rhabdomyosarcoma in a patient with Noonan syndrome. J Med Genet 1995; 32: 743-745.
16. Kondoh T, Ishii E, Aoki Y et al: Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report. Eur J Pediatr 2003; 162: 548-549. (Pubitemid 36904293)
17. Moschovi M, Touliatou V, Papadopoulou A, Mayakou MA, Nikolaidou- Karpathiou P, Kitsiou-Tzeli S: Rhabdomyosarcoma in a patient with Noonan syndrome phenotype and review of the literature. J Pediatr Hematol Oncol 2007; 29: 341-344. (Pubitemid 46707519)
18. Mutesa L, Pierquin G, Janin N et al: Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors. Cancer Genet Cytogenet 2008; 182: 40-42. (Pubitemid 351323957)
19. Bentires-Alj M, Paez JG, David FS et al: Activating mutations of the Noonan syndromeassociated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 2004; 64: 8816-8820. (Pubitemid 39665483)
20. Fryssira H, Leventopoulos G, Psoni S, Kitsiou-Tzeli S, Stavrianeas N, Kanavakis E: Tumor development in three patients with Noonan syndrome. Eur J Pediatr 2008; 167: 1025-1031.
21. Lee JS, Tartaglia M, Gelb BD et al: Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome. J Med Genet 2005; 42: e11.
22. Tartaglia M, Martinelli S, Stella L et al: Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 2006; 78: 279-290. (Pubitemid 43157567)
23. Loh ML, Vattikuti S, Schubbert S et al: Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 2004; 103: 2325-2331. (Pubitemid 38326253)
24. Tartaglia M, Niemeyer CM, Fragale A et al: Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34: 148-150. (Pubitemid 36666923)
25. Tartaglia M, Martinelli S, Iavarone I et al: Somatic PTPN11 mutations in childhood acute myeloid leukaemia. Br J Haematol 2005; 129: 333-339. (Pubitemid 40646891)
26. Miyamoto D, Miyamoto M, Takahashi A et al: Isolation of a distinct class of gain-offunction SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors. Oncogene 2008; 27: 3508-3515. (Pubitemid 351793798)
27. Casparie M, Tiebosch AT, Burger G et al: Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007; 29: 19-24. (Pubitemid 46535194)
28. Kratz CP, Niemeyer CM, Castleberry RP et al: The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/ myeloproliferative disease. Blood 2005; 106: 2183-2185. (Pubitemid 41291737)
29. Niihori T, Aoki Y, Ohashi H et al: Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia. J Hum Genet 2005; 50: 192-202. (Pubitemid 40685334)
30. Bader-Meunier B, Tchernia G, Mielot F et al: Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1997; 130: 885-889. (Pubitemid 27495115)
31. Silvio F, Carlo L, Elena B, Nicoletta B, Daniela F, Roberto M: Transient abnormal myelopoiesis in Noonan syndrome. J Pediatr Hematol Oncol 2002; 24: 763-764. (Pubitemid 35448745)
32. Lavin VA, Hamid R, Patterson J, Alford C, Ho R, Yang E: Use of human androgen receptor gene analysis to aid the diagnosis of JMML in female noonan syndrome patients. Pediatr Blood Cancer 2008; 51: 298-302. (Pubitemid 351874432)
33. Sherman CB, li-Nazir A, Gonzales-Gomez I, Finlay JL, Dhall G: Primary mixed glioneuronal tumor of the central nervous system in a patient with noonan syndrome: a case report and review of the literature. J Pediatr Hematol Oncol 2009; 31: 61-64.
34. Martinelli S, Carta C, Flex E et al: Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors. Cancer Genet Cytogenet 2006; 166: 124-129.
35. Schuettpelz LG, McDonald S, Whitesell K et al: Pilocytic astrocytoma in a child with Noonan syndrome. Pediatr Blood Cancer 2009; 53: 1147-1149.
36. Shaw AC, Kalidas K, Crosby AH, Jeffery S, Patton MA: The natural history of Noonan syndrome: a long-term follow-up study. Arch Dis Child 2007; 92: 128-132.
37. Yoshida R, Ogata T, Masawa N, Nagai T: Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation. Pediatr Blood Cancer 2008; 50: 1274-1276. (Pubitemid 351555559)
38. Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y: The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 2008; 29: 992-1006.
39. Jongmans M, Sistermans EA, Rikken A et al: Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature. Am J Med Genet A 2005; 134A: 165-170. (Pubitemid 40446212)
40. Jongmans MC, Hoogerbrugge PM, Hilkens L et al: Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma. Genes Chromosomes Cancer 2010; 49: 635-641.
41. Vogelstein B, Fearon ER, Hamilton SR et al: Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
42. Bentires-Alj M, Gil SG, Chan R et al: A role for the scaffolding adapter GAB2 in breast cancer. Nat Med 2006; 12: 114-121. (Pubitemid 43050085)
43. Sharif S, Moran A, Huson SM et al: Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 2007; 44: 481-484. (Pubitemid 47325733)
44. Keilhack H, David FS, McGregor M, Cantley LC, Neel BG: Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. J Biol Chem 2005; 280: 30984-30993. (Pubitemid 41291831)
45. Jenkins PJ, Mukherjee A, Shalet SM: Does growth hormone cause cancer? Clin Endocrinol (Oxf) 2006; 64: 115-121.
46. Ogilvy-Stuart AL, Gleeson H: Cancer risk following growth hormone use in childhood: implications for current practice. Drug Saf 2004; 27: 369-382. (Pubitemid 38608456)